Celldex Therapeutics reported $-72.79M in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
AbbVie USD 3.52B 828M Sep/2025
Amgen USD 5.91B 2.31B Sep/2025
Bristol-Myers Squibb USD 4.24B 967M Sep/2025
Celldex Therapeutics USD -72.79M 9.81M Sep/2025
Glaxosmithkline GBP 4.75B 1.52B Sep/2025
Pfizer USD 6.08B 351M Sep/2025
Roche Holding CHF 12.68B 2.36B Jun/2024